Thread by @AlbertVilella

#JPM2021 #LiquidBiopsy notable by their absence, which is more than excusable in these pandemic times: @freenome, Biocartis, Biodesix, Epic Sciences, ArcherDx (not by this name anyway). Worth following developments for them. In my book, worth following #Freenome of the ones here.

Smaller #LiquidBiopsy #Oncology #Diagnostics players also not at #JPM2021 but important in the field: Personalis, Inivata, Exosome Diagnostics, Epigenomics Ag, Personal Genome Diagnostics, Foundation Medicine, Singlera, Cambridge Epigenetix, and Bluestar Genomics.

Now added #BiologicalDynamics to my #LiquidBiopsy list crunchbase.com/organization/b… which displace #Biocept in the #Top30 bit.ly/liqbiop (thanks Kevin Han for the follow).

#JPM2021 #LiquidBiopsy @invitae: I didn't learn anything from the slide deck in the area of cancer diagnosis. Keeping an eye on them (bit.ly/liqbiop).

#JPM2021 @NeoGenomics : they do mention #LiquidBiopsy in their slide deck, in their NeoLAB suite. No mention of #epigenomics profiling.